Eli Lilly, Weight Loss Drug
We recently compiled a list of the 10 Best ESG Stocks To Buy Now. In this article, we are going to take a look at where Eli ...
Eli Lilly could be on its way to topping $1 trillion in market value. Meanwhile, Abbott launches its first over-the-counter ...
A recent announcement by Eli Lilly suggests that the company understands the economic conundrum some patients face. Per a ...
Today, patients on insulin receive injections daily, or even more often, but both companies are working to change that.
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.06% and ...
The deal would give Lilly access to Genetic Leap's proprietary AI platform to develop RNA-based medicines. Genetic medicines, ...
Many of the industry’s glitzy new buildings are showcasing impressive artwork by artists dealing with homelessness or living ...
Eli Lilly will license the manufacturing know-how for its rheumatoid arthritis treatment to Egypt's Eva Pharma, the companies ...
Eli Lilly has vaulted into an AI-enabled drug discovery deal, partnering with RNA specialist Genetic Leap in a pact worth up ...
Eli Lilly's weight loss treatment Zepbound might be a blockbuster in the making, but it wasn't without its challenges. See ...
Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries
Indianapolis: Eli Lilly and Company and EVA Pharma have announced that the companies have entered into an agreement to expand ...
Eli Lilly’s hunt for obesity targets has led it to the dark genome. | Eli Lilly’s hunt for obesity targets has led it to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results